Management of Large-Vessel Vasculitis Management of Large-Vessel Vasculitis
Get up-to-date on the latest advances in treatment options for large-vessel vasculitis.Current Opinion in Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 17, 2018 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news
Hypertension, Kidney Disease Linked with Vasculitis
(MedPage Today) -- Complications present in both adults and children with IgA vasculitis (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - November 29, 2018 Category: Pediatrics Source Type: news
Treatment of Pulmonary Vasculitis Treatment of Pulmonary Vasculitis
Learn more about the therapeutic management of pulmonary vasculitis and find out which factors may influence treatment choice.Seminars in Respiratory and Critical Care Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 27, 2018 Category: Consumer Health News Tags: Pulmonary Medicine Journal Article Source Type: news
Rituximab Promising in Childhood Vasculitis
(MedPage Today) -- Treatment was steroid-sparing in Hemoch-Schonlein purpura (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - November 15, 2018 Category: Pediatrics Source Type: news
Vasculitis Remission Predicts Long-Term Risks
(MedPage Today) -- Remission at months 3 and 6 protected against death and end-stage renal failure (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - November 14, 2018 Category: Primary Care Source Type: news
FDA approves label update for Roche ’s Mabthera/Rituxan (rituximab) in two rare forms of vasculitis
Roche announced today that the U.S. Food and Drug Administration (FDA) has approved an update to the MabThera/Rituxan ® (rituximab) label to include information on follow up treatment of adult patients with Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) who have achieved disease control with induction treatment. (Source: Roche Investor Update)
Source: Roche Investor Update - October 19, 2018 Category: Pharmaceuticals Source Type: news
Current and Emerging Therapies in Large-Vessel Vasculitis Current and Emerging Therapies in Large-Vessel Vasculitis
This review discusses the conventional treatments for large-vessel vasculitis as well as the potential of new biologic therapies.Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 15, 2018 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news
Vasculitis: A Link with IBD? (CME/CE)
(MedPage Today) -- High rates of Crohn ' s disease and ulcerative colitis seen in patients with giant cell arteritis (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - September 14, 2018 Category: Gastroenterology Source Type: news
Medical News Today: Skin cancer: Common IBD, arthritis drug may raise risk
A new study finds a link between a drug used widely to treat inflammatory bowel disease, arthritis, and vasculitis and a common form of skin cancer. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 12, 2018 Category: Consumer Health News Tags: Melanoma / Skin Cancer Source Type: news
Study links widely-used drug azathioprine to skin cancers
A drug used to treat inflammatory bowel disease, arthritis and vasculitis as well as to prevent organ rejection in transplant patients has been identified as an important contributor to skin cancer development, in a research study carried out at the University of Dundee, Queen Mary University of London and the Wellcome Sanger Institute. (Source: World Pharma News)
Source: World Pharma News - September 10, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Study links widely-used drug azathioprine to skin cancers
(University of Dundee) A drug used to treat inflammatory bowel disease, arthritis and vasculitis as well as to prevent organ rejection in transplant patients has been identified as an important contributor to skin cancer development.The research, published in Nature Communications, identified a `strong case for an association' between the drug azathioprine and the mutational signature found in cases of cutaneous squamous cell carcinoma (cSCC), a common form of skin cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 10, 2018 Category: Cancer & Oncology Source Type: news
Study links widely used drug azathioprine to skin cancers
(University of Dundee) A drug used to treat inflammatory bowel disease, arthritis and vasculitis as well as to prevent organ rejection in transplant patients has been identified as an important contributor to skin cancer development.The research, published in Nature Communications, identified a 'strong case for an association' between the drug azathioprine and the mutational signature found in cases of cutaneous squamous cell carcinoma (cSCC), a common form of skin cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 10, 2018 Category: Cancer & Oncology Source Type: news
Severe Vasculitis Linked to Cocaine Adulterant
(MedPage Today) -- Skin lesions prominent in levamisole-associated vasculitis (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - August 5, 2018 Category: Primary Care Source Type: news
How Common is Recurrent Kawasaki Disease?
Discussion
Kawasaki Disease (KD) was first described in 1967 by Dr. Tomisaku Kawasaki, and since has been identified world-wide. It is an acute, self-limited, febrile illness seen usually in children < 5 years. In North America the incidence is ~25/100,000 children < 5 years. Highest prevalence is seen in Asian children, particularly those of Japanese ancestry. Males are more common than females (~1.5:1). In Japan, case fatality rate is < 0.1%.
The cause is not identified although strong data suggests an interaction between infectious agents and genetic susceptibility. KD is a clinical diagnosis as is recurrent K...
Source: PediatricEducation.org - July 16, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
Watch for Infections in Rituximab-Treated Vasculitis
(MedPage Today) -- Prophylaxis with trimethoprim-sulfamethoxazole lowered the risk by half (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - June 29, 2018 Category: Primary Care Source Type: news
